Study of Mandibular Advancement Devices for Treating Obstructive Sleep Apnea Usage, Patient Experience, and Therapy Effectiveness

What this Trial Is About

Obstructive Sleep Apnea OSA is a condition where muscles in the throat relax during sleep, causing the tongue to fall back and narrowing the airway. This can lead to snoring or complete airway blockage, disrupting sleep and causing daytime sleepiness and increased risk for accidents and cardiovascular problems. The first treatment option is positive airway pressure PAP therapy using a mask, but some patients cannot tolerate this and may seek alternative treatments. One alternative being studied is the mandibular advancement device MAD, which fits in the mouth and pushes the lower jaw forward to keep the airway open during sleep. This registry study observes real-life use of MADs, including patient characteristics, therapy adherence, side effects, and how therapy costs are shared between patients and insurers. The study tracks changes in apnea severity and sleep quality over three months. Participants will provide information about their MAD use and health over a 3-month period. Researchers will assess apnea changes using the Apnea-Hypopnea Index AHI, sleep-related quality of life, daytime sleepiness, snoring, therapy satisfaction, side effects, and comorbid conditions. The study also documents how therapy is continued and reimbursed, helping understand patient pathways and therapy outcomes in everyday settings.

Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry